SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec® (imatinib mesylate) did not stop the cancer from growing or when you cannot take Gleevec.
Gleevec is a registered trademark of Novartis AG.
A Treatment Binder can help you and your loved one or Treatment Partner keep important
medical information organized. You can help by creating a binder with the following
sections:
- A calendar to keep track of the treatment schedule, doctor appointments, and prescription
refills. Build a SUTENT® calendar
- Laboratory tests
- Insurance information
- Educational materials the doctor or nurse provides